{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T09:52:11Z","timestamp":1793353931516,"version":"4.5.0"},"reference-count":28,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T00:00:00Z","timestamp":1755734400000},"content-version":"am","delay-in-days":354,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000050","name":"NHLBI","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002590","name":"American Lung Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002590","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","annallergy.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Allergy, Asthma & Immunology"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.anai.2024.06.011","type":"journal-article","created":{"date-parts":[[2024,6,17]],"date-time":"2024-06-17T06:08:49Z","timestamp":1718604529000},"page":"318-324","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Adoption and implementation of maintenance and reliever therapy for adults with moderate-to-severe asthma"],"prefix":"10.1016","volume":"133","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5091-1975","authenticated-orcid":false,"given":"Sandra E.","family":"Zaeh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zoe E.","family":"Zimmerman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle N.","family":"Eakin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geoffrey","family":"Chupp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.anai.2024.06.011_bib0001","unstructured":"Centers for Disease Control and Prevention. 2020 Healthcare use data. Accessed February 8, 2024. Available at: https:\/\/www.cdc.gov\/asthma\/healthcare-use\/2020\/data.htm"},{"issue":"6","key":"10.1016\/j.anai.2024.06.011_bib0002","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1016\/j.jaci.2020.10.003","article-title":"2020 Focused Updates to the Asthma Management Guidelines: A Report from the National Asthma Education and Prevention Program Coordinating Committee Expert Panel Working Group","volume":"146","author":"Cloutier","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.anai.2024.06.011_bib0003","unstructured":"Global Initiative for Asthma - GINA. 2021 GINA main report. Accessed January 15, 2022. Available at: https:\/\/ginasthma.org\/gina-reports\/"},{"issue":"2","key":"10.1016\/j.anai.2024.06.011_bib0004","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1164\/rccm.200407-884OC","article-title":"Budesonide\/formoterol combination therapy as both maintenance and reliever medication in asthma","volume":"171","author":"O'Byrne","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"10.1016\/j.anai.2024.06.011_bib0005","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1111\/resp.12009","article-title":"Budesonide\/formoterol maintenance and reliever therapy via Turbuhaler versus fixed-dose budesonide\/formoterol plus terbutaline in patients with asthma: phase III study results","volume":"18","author":"Atienza","year":"2013","journal-title":"Respirology"},{"issue":"1","key":"10.1016\/j.anai.2024.06.011_bib0006","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S2213-2600(13)70012-2","article-title":"Beclometasone-formoterol as maintenance and reliever treatment in patients with asthma: a double-blind, randomised controlled trial","volume":"1","author":"Papi","year":"2013","journal-title":"Lancet Respir Med"},{"issue":"9537","key":"10.1016\/j.anai.2024.06.011_bib0007","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/S0140-6736(06)69284-2","article-title":"Effect of budesonide in combination with formoterol for reliever therapy in asthma exacerbations: a randomised controlled, double-blind study","volume":"368","author":"Rabe","year":"2006","journal-title":"Lancet"},{"issue":"14","key":"10.1016\/j.anai.2024.06.011_bib0008","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1001\/jama.2018.2769","article-title":"Association of inhaled corticosteroids and long-acting \u03b2-agonists as controller and quick relief therapy with exacerbations and symptom control in persistent asthma: a systematic review and meta-analysis","volume":"319","author":"Sobieraj","year":"2018","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.anai.2024.06.011_bib0009","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/S2213-2600(13)70007-9","article-title":"Efficacy and safety of maintenance and reliever combination budesonide-formoterol inhaler in patients with asthma at risk of severe exacerbations: a randomised controlled trial","volume":"1","author":"Patel","year":"2013","journal-title":"Lancet Respir Med"},{"issue":"546","key":"10.1016\/j.anai.2024.06.011_bib0010","doi-asserted-by":"crossref","first-page":"37","DOI":"10.3399\/bjgp08X263802","article-title":"Poor adherence with inhaled corticosteroids for asthma: can using a single inhaler containing budesonide and formoterol help?","volume":"58","author":"Sovani","year":"2008","journal-title":"Br J Gen Pract"},{"issue":"10","key":"10.1016\/j.anai.2024.06.011_bib0011","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1111\/j.1398-9995.2007.01466.x","article-title":"Cost-effectiveness of budesonide\/formoterol for maintenance and reliever asthma therapy","volume":"62","author":"Price","year":"2007","journal-title":"Allergy"},{"issue":"1","key":"10.1016\/j.anai.2024.06.011_bib0012","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1186\/s12890-017-0492-5","article-title":"Physician perspectives on the burden and management of asthma in six countries: the Global Asthma Physician Survey (GAPS)","volume":"17","author":"Chapman","year":"2017","journal-title":"BMC Pulm Med"},{"issue":"7","key":"10.1016\/j.anai.2024.06.011_bib0013","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1111\/j.1365-2222.2011.03928.x","article-title":"The clinical impact of single inhaler therapy in asthma","volume":"42","author":"Czarnecka","year":"2012","journal-title":"Clin Exp Allergy"},{"issue":"3","key":"10.1016\/j.anai.2024.06.011_bib0014","doi-asserted-by":"crossref","first-page":"217","DOI":"10.3152\/147154403781776618","article-title":"Basic research and health: a reassessment of the scientific basis for the support of biomedical science","volume":"12","author":"Grant","year":"2003","journal-title":"Res Eval"},{"issue":"12","key":"10.1016\/j.anai.2024.06.011_bib0015","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1258\/jrsm.2011.110180","article-title":"The answer is 17 years, what is the question: understanding time lags in translational research","volume":"104","author":"Morris","year":"2011","journal-title":"J R Soc Med"},{"issue":"1","key":"10.1016\/j.anai.2024.06.011_bib0016","first-page":"65","article-title":"Managing clinical knowledge for health care improvement","volume":"1","author":"Balas","year":"2000","journal-title":"Yearb Med Inform"},{"key":"10.1016\/j.anai.2024.06.011_bib0017","unstructured":"Global Initiative for Asthma - GINA. 2023 GINA main report. Accessed May 15, 2023. Available at: https:\/\/ginasthma.org\/2023-gina-main-report\/"},{"issue":"9","key":"10.1016\/j.anai.2024.06.011_bib0018","doi-asserted-by":"crossref","first-page":"2757","DOI":"10.1016\/j.jaip.2023.04.041","article-title":"Patterns of asthma medication use in New Zealand after publication of national asthma guidelines","volume":"11","author":"Hatter","year":"2023","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"1","key":"10.1016\/j.anai.2024.06.011_bib0019","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.1016\/j.jaip.2021.10.011","article-title":"A practical guide to implementing SMART in asthma management","volume":"10","author":"Reddel","year":"2022","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"9","key":"10.1016\/j.anai.2024.06.011_bib0020","doi-asserted-by":"crossref","first-page":"2765","DOI":"10.1016\/j.jaip.2023.05.038","article-title":"Tracking the trends in the adoption of reliever-only ICS-formoterol therapy and SMART","volume":"11","author":"Zaeh","year":"2023","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"2","key":"10.1016\/j.anai.2024.06.011_bib0021","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1164\/ajrccm.160.2.9811100","article-title":"Exacerbations of asthma","volume":"160","author":"Tattersfield","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"issue":"9","key":"10.1016\/j.anai.2024.06.011_bib0022","article-title":"Inhaled steroids with and without regular formoterol for asthma: serious adverse events","volume":"2019","author":"Janjua","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.anai.2024.06.011_bib0023","first-page":"A6006","article-title":"Clinical practices and barriers to the use of single maintenance and reliever therapy for asthma","volume":"207","author":"Zaeh","year":"2023","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"10.1016\/j.anai.2024.06.011_bib0024","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/1748-5908-6-42","article-title":"The behaviour change wheel: a new method for characterising and designing behaviour change interventions","volume":"6","author":"Michie","year":"2011","journal-title":"Implement Sci"},{"issue":"9","key":"10.1016\/j.anai.2024.06.011_bib0025","doi-asserted-by":"crossref","first-page":"2767","DOI":"10.1016\/j.jaip.2023.05.023","article-title":"Beginning to address an implementation gap in asthma: clinicians\u2019 views of prescribing reliever budesonide-formoterol inhalers and SMART in the United States","volume":"11","author":"Krings","year":"2023","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"22","key":"10.1016\/j.anai.2024.06.011_bib0026","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1056\/NEJMoa2203163","article-title":"Albuterol\u2013budesonide fixed-dose combination rescue inhaler for asthma","volume":"386","author":"Papi","year":"2022","journal-title":"N Engl J Med"},{"issue":"16","key":"10.1016\/j.anai.2024.06.011_bib0027","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1056\/NEJMoa2118813","article-title":"Reliever-triggered inhaled glucocorticoid in Black and Latinx adults with asthma","volume":"386","author":"Israel","year":"2022","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.anai.2024.06.011_bib0028","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.chest.2023.09.004","article-title":"Implementing antiinflammatory reliever strategies in asthma: the evolving paradigm of asthma management","volume":"165","author":"Zaeh","year":"2024","journal-title":"Chest"}],"container-title":["Annals of Allergy, Asthma & Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1081120624003636?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1081120624003636?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,22]],"date-time":"2024-10-22T02:40:21Z","timestamp":1729564821000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1081120624003636"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":28,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["S1081120624003636"],"URL":"https:\/\/doi.org\/10.1016\/j.anai.2024.06.011","relation":{},"ISSN":["1081-1206"],"issn-type":[{"value":"1081-1206","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adoption and implementation of maintenance and reliever therapy for adults with moderate-to-severe asthma","name":"articletitle","label":"Article Title"},{"value":"Annals of Allergy, Asthma & Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anai.2024.06.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 American College of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}